Palpitations And Arrhythmia In 3649 High-Risk Patients With Essential Thrombocythemia : Results From The Prospective Long-Term Observational Exels Study
Robyn M. Scherber(Blueprint Medicines (United States)), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Heike L. Pahl(University Medical Center Freiburg), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Xuguo Sun, Catherine Harrison, Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Konstanze Doehner(University Hospital Ulm), Jan Samuelsson(Karolinska University Hospital), A.M. Vannucchi, F. Boyer, Jie Xu, M. Grieshammer, Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Holly L. Geyer(Mayo Clinic Hospital), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gabriel Étienne(Institut Bergonié), Karin Bonatz(Centre Hospitalier Universitaire de Grenoble), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Sonja Zweegman(Vrije Universiteit Amsterdam), P. Zhang, Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Peter Johansson(Sahlgrenska University Hospital), H. Schouten, Alfred Reiter(Justus-Liebig-Universität Gießen), Zhengrong Xu, Lieselot Le Roy, Peter A. te Boekhorst(Erasmus MC), F. Cervantes(Hospital Clínic de Barcelona), J Cahn(Leukemia Research Foundation), A Fuentes, Zhenya Senyak, T Barbui, Jean‐Jacques Kiladjian(Délégation Paris 5)
Haematologica
January 1, 2016
Cited by 2
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k